Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 15
Summary
- Conditions
- Behcet Syndrome
- Behcet's Disease
- Neuro-Behcet's Disease
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 16 years and 75 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01532570
- Collaborators
- Not Provided
- Investigators
- Study Director: Yoshiaki Ishigatsubo, MD, Ph.D Yokohama City University Graduate School of Medicine Study Director: Toshifumi Hibi, MD Kitasato University Kitasato Institute Hospital Study Director: Shunsei Hirohata, MD Kitasato University School of Medicine Study Director: Kazuoki Kondo, MD Mitsubihsi Tanabe Pharma Corporation
Get Well Soon